Alternatives to Neurosoft Bioelectronics

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Brain-computer interface for restoring communication and mobility for people with paralysis.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing a brain-computer interface for high-bandwidth neural data acquisition and stimulation.

Developing a cortical visual prosthesis to restore functional vision for the severely blind.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

Developing advanced vision restoration technology through a retinal implant.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing lightweight bionic technology.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing novel male contraceptives.

Develops a brain-computer interface for treating epilepsy.

Develops and distributes bioreactor technology for stem cell cultivation.

Developing a new histotripsy therapeutic platform for cancer treatment.

Elevating uterine health through innovative biomaterial therapies.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Develops advanced brain-computer interfaces (BCIs) to restore function and independence for individuals with neurological disorders.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

Developing breath-based diagnostics for lung diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions.

Non-invasive brain measurement technology for accessible brain health insights.

Motion-based driver monitoring using unconscious muscular submovements to detect cognitive state.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

Neurotechnology company analyzing brain signals from consumer headwear for real-time mind measurement.

OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Provides accessible, real-time brain data and insights for research and innovation.

AI-powered communication solutions for individuals with severe motor disabilities.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Enzyme-based technology to break down alcohol in the stomach.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.